Zhejiang Jianfeng Group's subsidiary, Jianfeng Pharmaceutical, passes drug GMP compliance inspection.

18:14 23/12/2025

Peak Group (600668.SH) announced that its wholly-owned subsidiary, Zhejiang Peak Pharmaceutical Co., Ltd., recently obtained the announcement of the GMP compliance inspection results (Zhe 2025 No. 0254) from the Zhejiang Province Food and Drug Administration website. This time, the fluocinolone acetonide active pharmaceutical ingredient production line of Peak Pharmaceutical passed the GMP compliance inspection, obtained the capability to supply raw materials for the drug, ensuring the production of fluocinolone acetonide eye drops, further enriching the company's product line.

Zhejiang Jianfeng Group (600668.SH) announced that its wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (referred to as "Jianfeng Pharmaceutical") recently received the announcement of the GMP compliance inspection results from the Zhejiang Provincial Drug Administration Agency (Zhejiang 2025 No. 0254) on their website. This time, Jianfeng Pharmaceutical's line for the production of Tofucinol raw materials passed the GMP compliance inspection, demonstrating its capability to supply raw materials for this drug, ensuring the production of Tofucinol eye drops, and further enriching the company's product line.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"